AMLX logo

Amylyx Pharmaceuticals, Inc. Common Stock

AMLX

AMLX: Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.

more

Show AMLX Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of AMLX by members of U.S. Congress

Recently reported changes by institutional investors

Quarterly net insider trading by AMLX's directors and management

Government lobbying spending instances

  • $80,000 Jul 17, 2023 Issue: Medicare/Medicaid Health Issues
  • $80,000 Apr 19, 2023 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jan 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $80,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jul 19, 2022 Issue: Medicare/Medicaid Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
WallStreetBets

Number of mentions of AMLX in WallStreetBets Daily Discussion

AMLX News

Recent insights relating to AMLX

CNBC Recommendations

Recent picks made for AMLX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AMLX

Corporate Flights

Flights by private jets registered to AMLX